Skip to main content
TipRanks
Go Ultimate75% OFF

Braveheart Bio, Inc. (BRVE) Income Statement

23 Followers

Braveheart Bio, Inc. Income Statement

Last quarter (Q3 2026), Braveheart Bio, Inc.'s total revenue was $0.00. In Q3, Braveheart Bio, Inc.'s net income was $-26.50M. See Braveheart Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25
$ 0.00
$ 0.00
$ 66.75M
Depreciation and Amortization$ 0.00
$ -66.75M
$ -66.75M
$ 0.00
$ -66.75M
$ -66.75M
Per Share Metrics
Basic EPS$ -5.32
Diluted EPS$ -5.32
Weighted Average Shares Outstanding12.41M
Weighted Average Shares Outstanding (Diluted)12.41M

Currency in USD

Braveheart Bio, Inc. Earnings and Revenue History

-75M-50M-25M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2025RevenueEarningsProfit Margin